Latest AI and machine learning research in pathology for healthcare professionals.
BACKGROUND: Cardiac amyloidosis (CA) is an underdiagnosed yet treatable cause of heart failure in wh...
Bisphenol A (BPA) is a prevalent environmental endocrine disruptor linked to breast cancer. However,...
BACKGROUND: Accurate preoperative prediction of renal tumor malignancy is critical for guiding decis...
Cryogenic electron tomography (cryoET) offers unparalleled views into the molecular architecture of ...
PURPOSE: To evaluate the performance of deep learning models using optical coherence tomography (OCT...
Progression to moderate-to-severe myelofibrosis (MF) in JAK2 V617F-positive myeloproliferative neopl...
Objectives: To develop a deep learning model based on magnetic resonance imaging (MRI) for the preop...
Traditional deep learning methods for motor fault diagnosis have primarily focused on signal-based c...
BACKGROUND AND OBJECTIVE: The Instantaneous wave-Free Ratio (iFR) is considered a potential alternat...
The Banff Classification, established in 1991, provides a global standard for diagnosing and grading...
OBJECTIVE: Pancreatic malignancies present major diagnostic challenges. The gold standard for diagno...
BACKGROUND: Glioblastoma (GBM) is the most common malignant glioma in adults. It has an extremely po...
BACKGROUND: While expression-based signatures inform adjuvant therapy in breast cancer (BC), no appr...
BACKGROUND: Sentinel node biopsy (SNB) provides pathological staging of the neck in T1/T2 node-negat...
Artificial intelligence (AI) is increasingly applied to biomedical research, but most current system...
Hepatocellular carcinoma (HCC) is a leading cause of cancer-related mortality. Machine learning (ML)...
Early liver metastasis is a major factor contributing to the poor prognosis of pancreatic ductal ade...
Prostate cancer (PCa) is the second most common malignancy in men worldwide, with rising mortality l...
Neurodisorders pose a considerable burden to global health, frequently requiring early treatment and...
Adverse events (AEs) of small molecule kinase inhibitors (SMKIs) at therapeutic doses in cancer pati...
BACKGROUND: Non-invasive biomarkers offer potential to improve risk stratification and early diagnos...